Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Canadian Research Sites (CRS) is a leading network of clinical research facilities across Canada, specializing in the execution of Phase I through IV clinical trials. The organization provides comprehensive services including site management, patient recruitment, and regulatory compliance for global pharmaceutical, biotechnology, and medical device sponsors. In November 2021, CRS merged with LMC Manna Research and IACT Health to form Centricity Research, establishing one of the largest integrated clinical research site networks in North America. CRS operates multiple high-performing sites in key Canadian markets, offering expertise in therapeutic areas such as endocrinology, neurology, infectious diseases, and vaccines. The network is distinguished by its centralized business operations and its ability to deliver high-quality clinical data and rapid patient enrollment. This integration allows the combined entity to offer sponsors access to a massive patient database and a diverse geographic footprint across Canada and the United States.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Canadian research sites.